Weimann Allan, Belling Dorthe, Poulsen Henrik E
Department of Clinical Pharmacology Q7642, Rigshospitalet, Tagensvej 20, DK-2200 Copenhagen N, Denmark.
Nucleic Acids Res. 2002 Jan 15;30(2):E7. doi: 10.1093/nar/30.2.e7.
Oxidative DNA damage, linked pathogenically to a variety of diseases such as cancer and ageing, can be investigated by measuring specific DNA repair products in urine. Within the last decade, since it was established that such products were excreted into urine, progress in their analysis in urine has been limited. Guanine is the DNA base most prone to oxidation. We present a method for determination of the urinary 8-hydroxylated species of guanine, based on direct injection of urine onto a high-performance liquid chromatography (HPLC)-tandem mass spectrometry system. The analysis covers the 8-hydroxylated base, ribonucleoside and deoxynucleoside, and the corresponding non-oxidised species. Without pre-treatment of urine the detection limits for the nucleobases are approximately 2 nM (50 fmol injected) and for the nucleosides approximately 0.5 nM (12.5 fmol injected). Previously, liquid chromatography of the nucleobases has been problematic but is made possible by low-temperature reverse-phase C18 chromatography, a method that increases retention on the column. In the case of the nucleosides, retention was almost total and provides a means for on-column concentration of larger urine samples and controlled high peak gradient elution. The total excretion of 8-hydroxylated guanine species was 212 nmol/24 h. The oxidised base accounted for 64%, the ribonucleoside for 23% and the deoxynucleoside for 13%, indicating substantial oxidation of RNA in humans. In rat urine, excretion of the oxidised base was more dominant, the percentages of the oxidised base, ribonucleoside and deoxynucleosides being 89, 8 and 3%. This finding is at odds with previous reports using immunoaffinity pre-purification and HPLC-electrochemical detection analysis. The developed method now makes it possible to measure oxidative nucleic acid stress to both RNA and DNA in epidemiological and intervention settings, and our findings indicate a substantial RNA oxidation in addition to DNA oxidation. The small volume needed also makes the method applicable to small experimental animals.
氧化性DNA损伤在致病方面与多种疾病相关,如癌症和衰老,可通过测量尿液中的特定DNA修复产物来进行研究。在过去十年里,自确定此类产物会排泄到尿液中以来,尿液中对它们的分析进展有限。鸟嘌呤是最易发生氧化的DNA碱基。我们提出了一种测定尿液中鸟嘌呤8 - 羟基化产物的方法,该方法基于将尿液直接注入高效液相色谱(HPLC)-串联质谱系统。该分析涵盖了8 - 羟基化碱基、核糖核苷和脱氧核苷以及相应的未氧化物种。无需对尿液进行预处理,碱基的检测限约为2 nM(进样50 fmol),核苷的检测限约为0.5 nM(进样12.5 fmol)。此前,碱基的液相色谱分析存在问题,但低温反相C18色谱法使其成为可能,该方法可增加在柱上的保留。对于核苷而言,保留几乎是完全的,这为更大体积尿液样本的柱上浓缩以及可控的高峰梯度洗脱提供了一种方法。8 - 羟基化鸟嘌呤物种的总排泄量为212 nmol/24小时。氧化碱基占64%,核糖核苷占23%,脱氧核苷占13%,表明人类RNA存在大量氧化。在大鼠尿液中,氧化碱基的排泄更为显著,氧化碱基、核糖核苷和脱氧核苷的百分比分别为89%、8%和3%。这一发现与先前使用免疫亲和预纯化和HPLC - 电化学检测分析的报告不一致。所开发的方法现在使得在流行病学和干预研究中测量RNA和DNA的氧化核酸应激成为可能,并且我们的发现表明除了DNA氧化外还存在大量的RNA氧化。所需的小体积也使得该方法适用于小型实验动物。